Advertisement Appropriate and Reliable Data Required for Conclusive FIH/Phase 1 trials - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Whitepapers

Appropriate and Reliable Data Required for Conclusive FIH/Phase 1 trials

Clinical trials are intended to find answers to a research question by generating data to prove or disprove a hypothesis. First-in-Human (FIH) and most Phase 1 trials by their very nature are exploratory, without a statistical hypothesis. They are aimed at obtaining reliable information on the safety, tolerability, pharmacokinetics and mechanism of action of a drug.

Please download this free white paper to read more.